Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TRVI | ADVM | AKYA | ||
| Company | Trevi Therapeutics Inc | Adverum Biotechnologies Inc | Akoya Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.93 | 9.60 | 3.86 | ||
| High | 3.00 | 10.24 | 4.10 | ||
| Low | 2.74 | 9.56 | 3.83 | ||
| Last | 2.86 | 9.79 | 3.96 | ||
| Change | -0.07 | +0.07 | +0.14 | ||
| % Change | -2.39% | +0.72% | +3.66% | ||
| Volume | 171,900 | 203,500 | 114,500 | ||
| 20-Day Average Volume | 187,120 | 311,935 | 148,750 | ||
| Previous Close | 2.93 | 9.72 | 3.82 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.84 | 11.16 | 4.01 | ||
| 20-Day Raw Stochastic | 56.66% | 19.09% | 30.77% | ||
| 20-Day Relative Strength | 50.39% | 33.23% | 40.29% | ||
| Weighted Alpha | -22.95 | -29.98 | -53.87 | ||
| Today's Opinion | 56% Buy | 56% Sell | 72% Sell | ||
| Previous Opinion | 56% Buy | 56% Sell | 72% Sell | ||
| Last Month's Opinion | 72% Buy | 8% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.92% since 04/24/24 | -3.93% since 04/24/24 | +3.94% since 04/24/24 | ||
| Low | 2.45 on 04/25/24 | 8.76 on 04/29/24 | 3.72 on 04/30/24 | ||
| High | 3.09 on 04/30/24 | 10.98 on 04/30/24 | 4.10 on 05/01/24 | ||
| 1-Month | |||||
| %Chg | -14.88% since 04/01/24 | -29.52% since 04/01/24 | -13.16% since 04/01/24 | ||
| Low | 2.35 on 04/17/24 | 8.76 on 04/29/24 | 3.72 on 04/30/24 | ||
| High | 3.30 on 04/02/24 | 14.16 on 04/04/24 | 4.51 on 04/02/24 | ||
| 3-Month | |||||
| %Chg | +105.76% since 02/01/24 | -17.73% since 02/01/24 | -28.78% since 02/01/24 | ||
| Low | 1.35 on 02/02/24 | 8.76 on 04/29/24 | 3.72 on 04/30/24 | ||
| High | 4.00 on 03/21/24 | 29.70 on 02/08/24 | 6.31 on 03/04/24 | ||
| 6-Month | |||||
| %Chg | +62.50% since 11/01/23 | +7.28% since 11/01/23 | +16.13% since 11/01/23 | ||
| Low | 0.97 on 11/27/23 | 7.40 on 12/29/23 | 3.50 on 11/02/23 | ||
| High | 4.00 on 03/21/24 | 29.70 on 02/08/24 | 6.31 on 03/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 201,444 | 203,191 | 195,545 | ||
| Shares Outstanding, K | 70,435 | 20,755 | 49,380 | ||
| Annual Sales | 0 | 3,600,000 | 96,630,000 | ||
| Annual Net Income | -29,070,000 | -117,170,000 | -63,320,000 | ||
| Last Quarter Sales | 0 | 0 | 26,490,000 | ||
| Last Quarter Net Income | -7,820,000 | -23,710,000 | -10,800,000 | ||
| 60-Month Beta | 0.91 | 0.89 | 1.52 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 03/20/24 | -2.30 on 03/18/24 | -0.22 on 03/04/24 | ||
| Latest Earnings Date | 05/09/24 | 05/09/24 | 05/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||